LEADER 02992nam 2200649Ia 450 001 9910465222303321 005 20200520144314.0 010 $a1-283-57735-6 010 $a9786613889805 010 $a0-19-978037-4 035 $a(CKB)2560000000089275 035 $a(EBL)995859 035 $a(OCoLC)806039918 035 $a(SSID)ssj0000704822 035 $a(PQKBManifestationID)12329285 035 $a(PQKBTitleCode)TC0000704822 035 $a(PQKBWorkID)10719611 035 $a(PQKB)11752415 035 $a(MiAaPQ)EBC995859 035 $a(Au-PeEL)EBL995859 035 $a(CaPaEBR)ebr10589616 035 $a(CaONFJC)MIL388980 035 $a(EXLCZ)992560000000089275 100 $a20120903d2012 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aDyslipidemia$b[electronic resource] /$fRagavendra R. Baliga, Christopher P. Cannon 210 $aOxford ;$aNew York $cOxford University Press$d2012 215 $a1 online resource (152 p.) 225 1 $aOxford American Cardiology Library 300 $aDescription based upon print version of record. 311 $a0-19-974286-3 320 $aIncludes bibliographical references and index. 327 $aCover; Contents; Contributors; 1 LDL Cholesterol; 2 HDL Cholesterol; 3 Non-HDL Cholesterol; 4 Use of High Sensitivity C-Reactive Protein for Risk Assessment; 5 Advanced Lipoprotein Testing: Assessment of Cardiovascular Risk and Therapy Beyond Standard Lipid Measurements; 6 Stratification of Dyslipidemic Risk; 7 Drugs for Treatment of Blood Lipoprotein Abnormalities; Index; A; B; C; D; E; F; G; H; I; J; K; L; M; N; O; P; Q; R; S; T; V; W; X; Z 330 $aDyslipidemia affects almost half of American adults and is the most prevalent manageable risk factor for atherosclerosis. Lipid disorders often co-occur with other prevalent conditions such as diabetes and kidney disease; they are also often a concern with certain medication regimens (such as anti-retroviral and certain anti-psychotic agents). Proper treatment of dyslipidemia can reduce the risk of peripheral arterial disease, revascularization procedures, nonfatal myocardial infarction, stroke, and cardiac death. However, only 20% of adults meet the national guidelines for cholesterol control 410 0$aOxford American Cardiology Library 606 $aLipids$xMetabolism$xDisorders$xTreatment 606 $aAtherosclerosis$xTreatment 606 $aCoronary heart disease 608 $aElectronic books. 615 0$aLipids$xMetabolism$xDisorders$xTreatment. 615 0$aAtherosclerosis$xTreatment. 615 0$aCoronary heart disease. 676 $a616.3/997 676 $a616.3997 701 $aBaliga$b R. R$0898694 701 $aCannon$b Christopher P$0893564 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910465222303321 996 $aDyslipidemia$92111881 997 $aUNINA